Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens

Journal of Infectious Diseases

Volumn 192, Issue 6, 2005, Pages 1108-1118

  Mutapi, Francisca ^a   Burchmore, Richard ^b   Mduluza, Takafira ^c   Foucher, Aude ^b,e   Harcus, Yvonne ^a   Nicoll, Gavin ^a   Midzi, Nicholas ^d   Turner, C Michael ^b   Maizels, Rick M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d NATIONAL INSTITUTE OF HEALTH RESEARCH   (Zimbabwe)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETICULIN; PARAMYOSIN; PARASITE ANTIGEN; PRAZIQUANTEL; TRIOSEPHOSPHATE ISOMERASE; TROPOMYOSIN; TROPOMYOSIN 1; TROPOMYOSIN 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL INFECTION; EXPOSURE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SEROLOGY; SERUM; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; ZIMBABWE;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HELMINTH PROTEINS; HUMANS; MASS SPECTROMETRY; PRAZIQUANTEL; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMICIDES; ZIMBABWE;

EID: 24644484703     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/432553     Document Type: Article

References (69)

1. World Health Organization, Tropical Disease Research. Schistosomiasis disease information. Available at: http://www.who.int/tdr/diseases/ schisto/diseaseinfo.htm. Accessed 6 April 2005.
2. World Health Organization. Initiative for Vaccine Research. Available at: http://www.who.int/vaccine_research/documents/new_vaccines/en/ index5.html. Accessed 6 April 2005.
3. Smithers RS, Gammage K. Recovery of Schistosoma mansoni from the skin, lungs and hepatic portal system of naive mice and mice previously exposed to S. mansoni: evidence for two phases of parasite attrition in immune mice. Parasitology 1980; 80:289-300.
4. Terry RJ. Human immunity to schistosomes: concomitant immunity. Parasitol Today 1994; 10:377-8.
5. Butterworth A, Capron M, Cordingley J, et al. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg 1985; 79:393-408.
6. Webbe G, Sturrock RF, James ER, James C. Schistosoma haematobium in the baboon (Papio anubis): effect of vaccination with irradiated larvae on the subsequent infection with percutaneously applied cercariae. Trans R Soc Trop Med Hyg 1982; 76:354-61.
7. Butterworth AE, Dunne DW, Fulford AJ, Ouma JH, Sturrock RF. Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects. Am J Trop Med Hyg 1996; 55:109-15.
8. Butterworth AE, Dunne DW, Fulford AJ, et al. Human immunity to Schistosoma mansoni: observations on mechanisms and implications for control. Immunol Invest 1992; 21:391-407.
9. Demeure CE, Rihet P, Abel L, Ouattara M, Bourgois A, Dessein AJ. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993; 168:1000-8.
10. Woolhouse MEJ, Hagan P. Seeking the ghost of worms past. Nat Med 1999; 5:1225-7.
11. Hagan P, Appleton CC, Coles GC, Kusel JR, Tchuem-Tchuente LA. Schistosomiasis control: keep taking the tablets. Trends Parasitol 2004; 20:92-7.
12. Beall JA, Mitchell GF. Identification of a particular antigen from a parasite cDNA library using antibodies affinity purified from selected portions of Western blots. J Immunol Methods 1986; 86:217-23.
13. Jeffs SA, Hagan P, Allen R, Correa-Oliveira R, Smithers SR, Simpson AJ. Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes. Mol Biochem Parasitol 1991; 46:159-67.
14. Lanar DE, Pearce EJ, Sher A. Expression in Escherichia coli of two Schistosoma mansoni genes that encode major antigens recognized by immune mice. Mol Biochem Parasitol 1985; 17:45-60.
15. McManus DP, Liu S, Song G, Xu Y, Wong JM. The vaccine efficacy of native paramyosin (Sj-97) against Chinese Schistosoma japonicum. Int J Parasitol 1998; 28:1739-42.
16. Goudot-Crozel V, Caillol D, Djabali M, Dessein AJ. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase. J Exp Med 1989; 170:2065-80.
17. Wilson RA, Curwen RS, Braschi S, Hall SL, Coulson PS, Ashton PD. From genomes to vaccines via the proteome. Mem Inst Oswaldo Cruz 2004; 99:45-50.
18. Verjovski-Almeida S, DeMarco R, Martins EA, et al. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 2003; 35:148-57.
19. Hu W, Yan Q, Shen DK, et al. Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet 2003; 35:139-47.
20. Curwen RS, Ashton PD, Johnston DA, Wilson RA. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol 2004; 138:57-66.
21. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 2003; 88:117-30.
22. Capron A, Capron M, Dombrowicz D, Riveau G. Vaccine strategies against schistosomiasis: from concepts to clinical trials. Int Arch Allergy Immunol 2001; 124:9-15.
23. Mutapi F. Heterogeneities in anti-schistosome humoral responses following chemotherapy. Trends Parasitol 2001; 17:518-24.
24. Lockyer AE, Olson PD, Ostergaard P, et al. The phylogeny of the Schistosomatidae based on three genes with emphasis on the interrelationships of Schistosoma Weinland, 1858. Parasitology 2003; 126:203-24.
25. Grogan J, Kremsner P, Vandam G, et al. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 1996; 173:1242-7.
26. Grogan JL, Kremsner PG, Deelder AJ, Yazdanbakhsh M. Elevated proliferation and interleukin-4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection. Eur J Immunol 1996; 26:1365-70.
27. Joseph S, Jones FM, Walter K, et al. Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. J Infect Dis 2004; 190:835-42.
28. Mutapi F, Ndhlovu PD, Hagan P, et al. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infect Dis 1998; 178:289-93.
29. Mutapi F, Hagan P, Ndhlovu P, Woolhouse MEJ. Comparison of humoral responses to Schistosoma haematobium in areas with high and low levels of infection. Parasite Immunol 1997; 19:255-63.
30. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
31. Mott KE. A reusable polyamide filter for diagnosis of S. haematobium infection by urine filtration. Bull Soc Pathol Exot Filiales 1983; 76:101-4.
32. Matsumoto Y, Perry G, Levine RJ, Blanton R, Mahmoud AA, Aikawa M. Paramyosin and actin in schistosomal teguments. Nature 1988; 333: 76-8.
33. Cook RM, Carvalho-Queiroz C, Wilding G, LoVerde PT. Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 2004; 72:6112-24.
34. Fonseca CT, Cunha-Neto E, Kalil J, et al. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells. Mem Inst Oswaldo Cruz 2004; 99:63-6.
35. Xu H, Miller S, van Keulen H, Wawrzynski MR, Rekosh DM, LoVerde PT. Schistosoma mansonii tropomyosin: cDNA characterization, sequence, expression, and gene product localization. Exp Parasitol 1989; 69:373-92.
36. El-Dabaa E, Mei H, El-Sayed A, et al. Cloning and characterization of Schistosoma mansoni fructose-1,6-bisphosphate aldolase isoenzyme. J Parasitol 1998; 84:954-60.
37. Argilo L, Kohlstadt S, Henri S, et al. Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH. Vaccine 2000; 18:2039-48.
38. Lee KW, Shalaby KA, Thakur A, Medhat AM, Karim AM, LoVerde PT. Cloning of the gene for phosphoglycerate kinase from Schistosoma mansoni and characterization of its gene product. Mol Biochem Parasitol 1995; 71:221-31.
39. Lee KW, Thakur A, Karim AM, LoVerde PT. Immune response to Schistosoma mansoni phosphoglycerate kinase during natural and experimental infection: identification of a schistosome-specific B-cell epitope. Infect Immun 1995; 63:4307-11.
40. Shoemaker C, Gross A, Gebremichael A, Harn D. cDNA cloning and functional expression of the Schistosoma mansoni protective antigen triose-phosphate isomerase. Proc Natl Acad Sci USA 1992; 89:1842-6.
41. Porchet E, McNair A, Caron A, Kusnierz J, Zemzoumi K, Capron A. Tissue expression of the Schistosoma mansoni 28kDa glutathione S-transferase. Parasitology 1994; 109:565-72.
42. Riveau G, Poulain-Godefroy OP, Dupre L, et al. Glutathione S-transferases of 28kDa as major vaccine candidates against schistosomiasis. Mem Inst Oswalde Cruz 1998; 93(Suppl 1):S87-94.
43. Kremer L, Dupre L, Riveau G, Capron A, Locht C. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing glutathione S-transferase from Schistosoma haematobium. Infect Immun 1998; 66:5669-76.
44. Dupre L, Poulain Godefroy O, Ban E, et al. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol 1997; 19:505-13.
45. Bashir M, Bickle Q, Bushara H, et al. Evaluation of defined antigen vaccines against Schistosoma bovis and S. japonicum in bovines. Trop Geogr Med 1994; 46:255-8.
46. Auriault C, Gras-Masse H, Pierce RJ, et al. Antibody response of Schistosoma mansoni infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides. J Clin Microbiol 1990; 28:1918-24.
47. Tielens AG, van den Heuvel JM, van Eden W. Schistosoma mansoni: an HSP60 homologue is constitutively expressed in cercariae, adults, and sporocysts. Exp Parasitol 1993; 77:495-7.
48. Hedstrom R, Culpepper J, Harrison RA, Agabian N, Newport G. A major immunogen in Schistosoma mansoni infections is homologous to the heat-shock protein Hsp70. J Exp Med 1987; 165:1430-5.
49. Hedstrom R, Culpepper J, Schinski V, Agabian N, Newport G. Schistosome heat-shock proteins are immunologically distinct host-like antigens. Mol Biochem Parasitol 1988; 29:275-82.
50. Osman A, Kiang D, Lo Verde P, Karim AM. Schistosoma mansoni: characterisation of p50, an immunophilin. Exp Parasitol 1995; 80:550-9.
51. Zhang Y, Taylor MG, McCrossan MV, Bickle QD. Molecular cloning and characterization of a novel Schistosoma japonicum "irradiated vaccine-specific" antigen, Sj14-3-3. Mol Biochem Parasitol 1999; 103:25-34.
52. Schechtman D, Tarrab-Hazdai R, Arnon R. The 14-3-3 protein as a vaccine candidate against schistosomiasis. Parasite Immunol 2001; 23: 213-7.
53. Khalife I, Trottein F, Schacht AM, Godin C, Pierce RJ, Capron A. Cloning of the gene encoding a Schistosoma mansoni antigen homologous to human Ro/SS-A autoantigen. Mol Biochem Parasitol 1993; 57:193-202.
54. Brito CF, Oliveira GC, Oliveira SC, et al. Sm14 gene expression in different stages of the Schistosoma mansoni life cycle and immunolocalization of the Sm14 protein within the adult worm. Braz J Med Biol Res 2002; 35:377-81.
55. Ribeiro F, Vieira Cdos S, Fernandes A, Araujo N, Katz N. The effects of immunization with recombinant Sm14 (rSm14) in reducing worm burden and mortality of mice infected with Schistosoma mansoni. Rev Soc Bras Med Trop 2002; 35:11-7.
56. Brito CFA, Fonseca CT, Goes AM, Azevedo V, Simpson AIG, Oliveira SC. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14 kDa fatty acid-binding recombinant protein. Parasite Immunol 2000; 22:41-8.
57. Agnew AM, Murare HM, Doenhoff MJ. Immune attrition of adult schistosomes. Parasite Immunol 1993; 15:261-71.
58. Maizels RM, Bundy DAP, Selkirk ME, Smith DF, Anderson RM. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993; 365:797-805.
59. Pearce EJ, James SL, Hieny S, Lanar DE, Sher A. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Proc Natl Acad Sci USA 1988; 85:5678-82.
60. Li BW, Chandrashekar R, Weil GJ. Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds. J Immunol 1993; 150:1881-5.
61. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 1997; 66:209-30.
62. Solis CF, Vazquez-Talavera J, Laclette JP. Toward development of a Taenia solium paramyosin-based vaccine against porcine cysticercosis. Gac Med Mex 2004; 140:129-38.
63. Andrews P. Praziquantel: mechanisms of anti-schistosomal activity. Pharmacol Ther 1985; 29:129-56.
64. Fallon PG, Doenhoff MJ. Active immunisation of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel. Parasite Immunol 1995; 17:261-8.
65. Linder E, Thors C. Schistosoma mansoni praziquantel-induced tegumental lesion exposes actin of surface spines and allows binding of actin depolymerizing factor, gelsolin. Parasitology 1992; 105:71-9.
66. Redman C, Robertson PG, Fallon J, et al. Praziquantel: an urgent and exciting challenge. Parasitol Today 1996; 12:14-20.
67. Fallon PG, McNeice C, Probert AJ, Doenhoff MJ. Quantification of praziquantel-induced damage on the surface of adult Schistosoma mansoni worms: estimation of esterase and alkaline phosphatase activity. Parasitol Res 1994; 80:623-5.
68. Mutapi F, Hagan P, Woolhouse ME, Mduluza T, Ndhlovu PD. Chemotherapy-induced, age-related changes in antischistosome antibody responses. Parasite Immunol 2003; 25:87-97.
69. Mutapi F, Hagan P, Ndhlovu P, Woolhouse MEJ. Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children. Parasite Immunol 1998; 20: 595-600.